LYCA

33.0704.09%
JP

Jane Pritchett V. Henderson

Independent Director

Ms. Jane Pritchett V. Henderson was Director of CARGO Therapeutics, Inc. from June 2024 until August 18, 2025. She is an Independent Director of Lycia Therapeutics, Inc. from July 06, 2026. Ms. Henderson served as Chief Financial Officer at Apogee Therapeutics, Inc. since joined on January 2023 until September 3, 2026. She serves on Board of Directors of Ventus Therapeutics U.S., Inc. since December 7, 2021. She served as Treasurer of Invivyd, Inc. (formerly known as Adagio Therapeutics, Inc.). Ms. Henderson has experience as a health care investment banker and financial leader at several biotechnology companies. She has been an Independent Director of IVERIC Bio, Inc. (formerly, Ophthotech Corp.) since January 16, 2018. She had been Chief Financial Officer of Invivyd, Inc. (formerly known as Adagio Therapeutics, Inc.) since December 2020 until October 2022 and served as Chief Business Officer since March 18, 2022 until October 2022. She served as the Chief Financial Officer and Senior Vice President of Corporate Development at Voyager Therapeutics, Inc. from January 1, 2017 until June 08, 2018. Ms. Henderson served as an Independent Director at Akero Therapeutics, Inc. since April 23, 2019 until December 9, 2025. Ms. Henderson served as the Chief Financial Officer of Turnstone Biologics, Inc. from June 2018 to December 2020. Ms. Henderson joined Voyager on January 1, 2017. She served as the Chief Financial & Business Officer of Kolltan Pharmaceuticals, Inc. and its Senior Vice President from February 2013 to November 2016. Ms. Henderson has finance experience in the life sciences industry. She served as Chief Business Officer and Vice President of Kolltan Pharmaceuticals, Inc. since joining it in February 2013 and leading the sale of Kolltan to Celldex Pharmaceuticals, Inc., in November 2016. She joined Kolltan in 2013. She served as Vice President of Business Development at ISTA Pharmaceuticals, Inc. from June 2010 to June 2012, where she managed the process that culminated in the acquisition of ISTA by Bausch + Lomb. Prior to Kolltan Pharmaceuticals, Ms. Henderson served in various financial and business development executive roles at biopharmaceutical companies after spending almost 20 years in health care investment banking. She served as the Chief Financial Officer and Chief Business Officer of Panacos Pharmaceuticals Inc. from January 7, 2008 to February 2009. She served as Treasurer, Secretary and Executive Vice President of Panacos Pharmaceuticals Inc., from January 2008 to February 2009. In this role, she was responsible for Panacos' financial operations, compliance and reporting and corporate financing activities as well as contributing to corporate strategy. Ms. Henderson served as Executive Vice President, Chief Financial Officer and Chief Business Officer of Axerion Pharmaceuticals, Inc. from September 2009 to June 2010. She held senior investment banking positions for close to two decades in the health care groups of HSBC Securities, CIBC World Markets, Lehman Brothers and Salomon Brothers. She served as Managing Director of investment banking division covering biotechnology companies at HSBC Bank plc since July 2005, where she was responsible for global origination and execution of biopharmaceutical business on a new investment banking platform. Prior to HSBC, she was with CIBC World Markets, where she served as Managing Director in the health care group. In her career, she held senior positions in healthcare investment banking at Lehman Brothers and Salomon Smith Barney (Citigroup). Ms. Henderson was Managing Director and held other senior roles at HSBC Holdings plc, Canadian Imperial Bank of Commerce, Lehman Brothers and Salomon Brothers. She had been a Director of Sesen Bio Inc. since October 2013 until November 22, 2021 and serves as its CEO Advisor since November 22, 2021. She served as a Member of Global Healthcare Team of HSBC Bank PLC since July 2005. She serves as Secretary and Treasurer of The EQUUS Foundation in Westport, CT. Ms. Henderson holds a B.S. in Psychology from the Duke University.

Positions